Engineering the gut microbiota to treat chronic diseases.

Dosoky NS, May-Zhang LS, Davies SS
Appl Microbiol Biotechnol. 2020 104 (18): 7657-7671

PMID: 32696297 · PMCID: PMC7484268 · DOI:10.1007/s00253-020-10771-0

Gut microbes play vital roles in host health and disease. A number of commensal bacteria have been used as vectors for genetic engineering to create living therapeutics. This review highlights recent advances in engineering gut bacteria for the treatment of chronic diseases such as metabolic diseases, cancer, inflammatory bowel diseases, and autoimmune disorders. KEY POINTS: • Bacterial homing to tumors has been exploited to deliver therapeutics in mice models. • Engineered bacteria show promise in mouse models of metabolic diseases. • Few engineered bacterial treatments have advanced to clinical studies.

MeSH Terms (7)

Animals Bacteria Chronic Disease Gastrointestinal Microbiome Inflammation Inflammatory Bowel Diseases Mice

Connections (1)

This publication is referenced by other Labnodes entities:

Links